Literature DB >> 2261644

Mutations in v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene.

M Introna1, J Golay, J Frampton, T Nakano, S A Ness, T Graf.   

Abstract

Chick myelomonocytic cells transformed by the v-myb oncogene-containing viruses E26 and AMV differ in that the former resemble myeloblasts and express the v-myb-regulated granulocyte-specific mim-1 gene, while the latter resemble monoblasts and are mim-1 negative. We constructed a series of AMV-E26 chimeras and localized the critical differences between these viruses to three point mutations within the second repeat of the v-myb DNA binding domain. These three positions are altered in the v-myb protein of AMV relative to the proteins encoded by c-myb or E26 v-myb. Back mutating AMV v-myb at any of these three sites restored the oncogene's ability to activate the mim-1 gene. Surprisingly, two of these changes led to the transformation, in vitro and in vivo, of cells having a promyelocyte-like phenotype. These results indicate that different forms of v-myb impose alternate phenotypes of differentiation on transformed myeloid cells, probably by regulating unique sets of differentiation-specific genes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2261644     DOI: 10.1016/0092-8674(90)90424-d

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  45 in total

1.  tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.

Authors:  O Burk; S Worpenberg; B Haenig; K H Klempnauer
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

2.  Identification of a novel vertebrate homeobox gene expressed in haematopoietic cells.

Authors:  M R Crompton; T J Bartlett; A D MacGregor; G Manfioletti; E Buratti; V Giancotti; G H Goodwin
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

3.  v-Myb mediates cooperation of a cell-specific enhancer with the mim-1 promoter.

Authors:  Olesya Chayka; Jörg Kintscher; Daniel Braas; Karl-Heinz Klempnauer
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

4.  Protein truncation is required for the activation of the c-myb proto-oncogene.

Authors:  F A Grässer; T Graf; J S Lipsick
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

5.  Interaction of C/EBPbeta and v-Myb is required for synergistic activation of the mim-1 gene.

Authors:  S Mink; U Kerber; K H Klempnauer
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

6.  The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells.

Authors:  S C Kenney; E Holley-Guthrie; E B Quinlivan; D Gutsch; Q Zhang; T Bender; J F Giot; A Sergeant
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

7.  Differential transcriptional activation by v-myb and c-myb in animal cells and Saccharomyces cerevisiae.

Authors:  R H Chen; J S Lipsick
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

8.  The glioma-amplified sequence 41 gene (GAS41) is a direct Myb target gene.

Authors:  Daniel Braas; Holger Gundelach; Karl-Heinz Klempnauer
Journal:  Nucleic Acids Res       Date:  2004-09-08       Impact factor: 16.971

9.  Degeneration of skeletal and cardiac muscles in c-myb transgenic mice.

Authors:  Y Furuta; S Aizawa; Y Suda; Y Ikawa; H Nakasgoshi; Y Nishina; S Ishii
Journal:  Transgenic Res       Date:  1993-07       Impact factor: 2.788

10.  c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.

Authors:  Shenghao Jin; Huiwu Zhao; Yan Yi; Yuji Nakata; Anna Kalota; Alan M Gewirtz
Journal:  J Clin Invest       Date:  2010-01-19       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.